- Home
- IIPR vs IMNM Comparison
IIPR vs IMNM Comparison
Compare IIPR & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIPR
- IMNM
- Stock Information
- Founded
- IIPR 2016
- IMNM 2006
- Country
- IIPR United States
- IMNM United States
- Employees
- IIPR N/A
- IMNM N/A
- Industry
- IIPR Real Estate
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- IIPR Finance
- IMNM Health Care
- Exchange
- IIPR Nasdaq
- IMNM Nasdaq
- Market Cap
- IIPR 1.5B
- IMNM 1.2B
- IPO Year
- IIPR 2016
- IMNM 2020
- Fundamental
- Price
- IIPR $49.37
- IMNM $18.38
- Analyst Decision
- IIPR Hold
- IMNM Strong Buy
- Analyst Count
- IIPR 8
- IMNM 8
- Target Price
- IIPR $88.50
- IMNM $25.75
- AVG Volume (30 Days)
- IIPR 322.8K
- IMNM 1.4M
- Earning Date
- IIPR 11-03-2025
- IMNM 11-06-2025
- Dividend Yield
- IIPR 15.35%
- IMNM N/A
- EPS Growth
- IIPR N/A
- IMNM N/A
- EPS
- IIPR 4.24
- IMNM N/A
- Revenue
- IIPR $276,042,000.00
- IMNM $9,679,000.00
- Revenue This Year
- IIPR N/A
- IMNM N/A
- Revenue Next Year
- IIPR N/A
- IMNM $85.36
- P/E Ratio
- IIPR $11.69
- IMNM N/A
- Revenue Growth
- IIPR N/A
- IMNM N/A
- 52 Week Low
- IIPR $44.58
- IMNM $5.15
- 52 Week High
- IIPR $112.17
- IMNM $19.16
- Technical
- Relative Strength Index (RSI)
- IIPR 47.62
- IMNM 61.57
- Support Level
- IIPR $44.58
- IMNM $17.96
- Resistance Level
- IIPR $50.39
- IMNM $19.16
- Average True Range (ATR)
- IIPR 1.44
- IMNM 1.18
- MACD
- IIPR 0.22
- IMNM 0.01
- Stochastic Oscillator
- IIPR 62.24
- IMNM 80.81
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.